Investors Overview

Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in ...
More

Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$5.01
Change (%) Stock is Up 0.01 (0.20%)
Volume57,182
Data as of 09/19/14 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
09/18/14Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference
BELGRADE, Mont., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CEO, Dan Goldberger, will present at the Singular Research 9th Annual Best of the Uncovereds Conference, to be held September 22, 2014 at the Luxe Hotel in Los Angeles, CA. Bacterin's presentation will take place Monday, September 22, 2014 at 9:00am PT. Institutional ... 
Printer Friendly Version
08/13/14Bacterin Announces the Appointment of New Board Member
BELGRADE, Mont., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of David Goodman, MD, MSE to the board of directors. Dr. Goodman brings extensive experience in executive management through previous roles as CEO of SEDLine and EVP of Business Development for Masimo (Nasdaq:MASI). The Board unanimously elected Dr. Good... 
Printer Friendly Version
08/12/14Bacterin Announces Second Quarter 2014 Results
Second Quarter 2014 Revenues Increase Approximately 7.5% Over Second Quarter 2013 BELGRADE, Mont., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today reported financial results for the second quarter ended June 30, 2014. The Company reported quarterly revenues of approximately $8.9 million, and a net loss for the quarter of approximately ($1.9) million, or ($0.35... 
Printer Friendly Version
08/12/14Bacterin Announces Publication in The Spine Journal Featuring OsteoSelect DBM Putty
BELGRADE, Mont., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today The Spine Journal has published positive results reported on the evaluation of OsteoSelect® DBM Putty in a rabbit posterolateral spinal fusion model. The study was completed by the Integrated Spine Research Department at the Hospital for Special Surgery in New York. The st... 
Printer Friendly Version
More

Upcoming Events
DateTitle
09/22/14 9:00 a.m. PT
Bacterin International Holdings Inc at the Singular Research 9th Annual Best of the Uncovereds Conference
LocationLuxe HotelLos Angeles, CA
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.